| Articles Reviewed |
| 1: | Takashi Koto et al. Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. 2007 |
| 2: | Maria I Harrell et al. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. 2007 |
| 3: | T Misu et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. 2007 |
| 4: | John A Taylor et al. Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice. 2007 |
| 5: | Robert B Rebhun et al. Targeting receptor tyrosine kinase on lymphatic endothelial cells for the therapy of colon cancer lymph node metastasis. 2006 |
| 6: | Chung-Hyun Cho et al. COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model. 2006 |
| 7: | Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |
| 8: | Takumi Shibuya et al. Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin. 2006 |
| 9: | Ulrike Fiedler et al. The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors. 2006 |
| 10: | Vitezslav Kriz et al. The SHB adapter protein is required for normal maturation of mesoderm during in vitro differentiation of embryonic stem cells. 2006 |
| 11: | Marko Salmi et al. Developmental regulation of the adhesive and enzymatic activity of vascular adhesion protein-1 (VAP-1) in humans. 2006 |
| 12: | Y Ishikawa et al. The human renal lymphatics under normal and pathological conditions. 2006 |
| 13: | Alexandra Gellhaus et al. Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia. 2006 |
| 14: | Lei Xu et al. Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model. 2005 |
| 15: | Kazuichi Maruyama et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. 2005 |
| 16: | Li-Xing Man et al. Lentiviral gene therapy with platelet-derived growth factor B sustains accelerated healing of diabetic wounds over time. 2005 |
| 17: | Shuqing Liu et al. Cross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenografts. 2005 |
| 18: | Fuminori Sato et al. Effects of hormone deprivation and 2-methoxyestradiol combination therapy on hormone-dependent prostate cancer in vivo. 2005 |
| 19: | Anders Bratt et al. Angiomotin regulates endothelial cell-cell junctions and cell motility. 2005 |
| 20: | Sophia Ran et al. The vascular-ablative agent VEGF(121)/rGel inhibits pulmonary metastases of MDA-MB-231 breast tumors. 2005 |
| 21: | Makoto Murakami et al. Cellular distribution, post-translational modification, and tumorigenic potential of human group III secreted phospholipase A(2). 2005 |
| 22: | Il-Man Kim et al. The forkhead box m1 transcription factor is essential for embryonic development of pulmonary vasculature. 2005 |
| 23: | Henriette E U Meyer Zu Schwabedissen et al. Expression, localization, and function of MRP5 (ABCC5), a transporter for cyclic nucleotides, in human placenta and cultured human trophoblasts: effects of gestational age and cellular differentiation. 2005 |
| 24: | Ping Guo et al. Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma. 2005 |
| 25: | Luisa Campagnolo et al. EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury. 2005 |
| 26: | Marta GarcÃa-RamÃrez et al. Transcription factor SOX18 is expressed in human coronary atherosclerotic lesions and regulates DNA synthesis and vascular cell growth. 2005 |
| 27: | Kentaro Kajiya et al. Hepatocyte growth factor promotes lymphatic vessel formation and function. 2005 |
| 28: | Frank Kuhnert et al. Dosage-dependent requirement for mouse Vezf1 in vascular system development. 2005 |
| 29: | Ugur Ozerdem et al. Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis. 2005 |
| 30: | Stefanie Diehl et al. Altered expression patterns of EphrinB2 and EphB2 in human umbilical vessels and congenital venous malformations. 2005 |
| 31: | Diane R Bielenberg et al. Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. 2004 |
| 32: | Benjamin F Chong et al. E-selectin, thymus- and activation-regulated chemokine/CCL17, and intercellular adhesion molecule-1 are constitutively coexpressed in dermal microvessels: a foundation for a cutaneous immunosurveillance system. 2004 |
| 33: | Atsushi Suzuki et al. ARK5 is a tumor invasion-associated factor downstream of Akt signaling. 2004 |
| 34: | Fang Yan et al. Kinase suppressor of Ras-1 protects intestinal epithelium from cytokine-mediated apoptosis during inflammation. 2004 |
| 35: | Anneke Engering et al. Dynamic populations of dendritic cell-specific ICAM-3 grabbing nonintegrin-positive immature dendritic cells and liver/lymph node-specific ICAM-3 grabbing nonintegrin-positive endothelial cells in the outer zones of the paracortex of human lymph nodes. 2004 |
| 36: | Soichi Tsutsumi et al. Autocrine motility factor signaling enhances pancreatic cancer metastasis. 2004 |
| 37: | Pirjo Laakkonen et al. Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells. 2004 |
| 38: | Soheil S Dadras et al. Infantile hemangiomas are arrested in an early developmental vascular differentiation state. 2004 |
| 39: | Allen D Everett et al. Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor. 2004 |
| 40: | Karïn Gogat et al. VEGF and KDR gene expression during human embryonic and fetal eye development. 2004 |
| 41: | David R Hinton et al. Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy. 2004 |
| 42: | Dominique Stickens et al. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. 2004 |
| 43: | Pia Wülfing et al. Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer. 2004 |
| 44: | W Liu et al. Effects of overexpression of ephrin-B2 on tumour growth in human colorectal cancer. 2004 |
| 45: | M M Vleugel et al. Lack of lymphangiogenesis during breast carcinogenesis. 2004 |
| 46: | Ryoko Yamauchi et al. Upregulation of SR-PSOX/CXCL16 and recruitment of CD8+ T cells in cardiac valves during inflammatory valvular heart disease. 2004 |
| 47: | Yu-Wen Zhang et al. Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. 2003 |
| 48: | Jean-Marie Rakic et al. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. 2003 |
| 49: | Keisuke Horiuchi et al. Potential role for ADAM15 in pathological neovascularization in mice. 2003 |
| 50: | Takashi Karashima et al. Nuclear factor-kappaB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8. 2003 |
| 51: | Alexander M Simon et al. Decreased intercellular dye-transfer and downregulation of non-ablated connexins in aortic endothelium deficient in connexin37 or connexin40. 2003 |
| 52: | Florian Gruber et al. Direct binding of Nur77/NAK-1 to the plasminogen activator inhibitor 1 (PAI-1) promoter regulates TNF alpha -induced PAI-1 expression. 2003 |
| 53: | Tetsuro Watabe et al. TGF-beta receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells. 2003 |
| 54: | Hee-Jae Cha et al. Role of thymosin beta4 in tumor metastasis and angiogenesis. 2003 |
| 55: | Zheng Fu et al. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. 2003 |
| 56: | Vivien Schacht et al. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. 2003 |
| 57: | M Llanos Casanova et al. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. 2003 |
| 58: | Tomowaki Nakagawa et al. HEX acts as a negative regulator of angiogenesis by modulating the expression of angiogenesis-related gene in endothelial cells in vitro. 2003 |
| 59: | Nadine Pavlov et al. Angiogenin distribution in human term placenta, and expression by cultured trophoblastic cells. 2003 |
| 60: | Takehiro Nitta et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. 2003 |
| 61: | Michael I Koukourakis et al. Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients. 2003 |
| 62: | Fabio Cianchi et al. Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis. 2003 |
| 63: | Rafia S Al-Lamki et al. Expression of silencer of death domains and death-receptor-3 in normal human kidney and in rejecting renal transplants. 2003 |
| 64: | Raffaella Giavazzi et al. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 2003 |
| 65: | Klaus Ebnet et al. The junctional adhesion molecule (JAM) family members JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: a possible role for JAMs in endothelial cell polarity. 2003 |
| 66: | Claus Cursiefen et al. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. 2002 |
| 67: | Anne Corbaz et al. IL-18-binding protein expression by endothelial cells and macrophages is up-regulated during active Crohn's disease. 2002 |
| 68: | Michiyo Saimura et al. Tumor suppression through angiogenesis inhibition by SUIT-2 pancreatic cancer cells genetically engineered to secrete NK4. 2002 |
| 69: | Kumi Yasukawa et al. Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease. 2002 |
| 70: | Yasuo Saijo et al. Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction. 2002 |
| 71: | Simona Podgrabinska et al. Molecular characterization of lymphatic endothelial cells. 2002 |
| 72: | Samuel F Huang et al. Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel. 2002 |
| 73: | Virginia Urquidi et al. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. 2002 |
| 74: | Judith C Kim et al. Novel expression of vascular cell adhesion molecule-1 (CD106) by squamous epithelium in experimental acute graft-versus-host disease. 2002 |
| 75: | C Hanselmann et al. Haem oxygenase-1: a novel player in cutaneous wound repair and psoriasis?. 2001 |
| 76: | B Möller et al. Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle. 2001 |
| 77: | A D Dick et al. Distribution of OX2 antigen and OX2 receptor within retina. 2001 |
| 78: | SJ Mandriota et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis.. 2001 |